These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4254977)

  • 1. The influence of cinanserin and selected pharmacologic agents on experimental allergic encephalomyelitis (EAE).
    Babington RG; Wedeking PW
    J Pharmacol Exp Ther; 1971 May; 177(2):454-60. PubMed ID: 4254977
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of various immunosuppressive drugs on experimental allergic encephalomyelitis in chickens.
    Blaszczyk B; Karakoz I; Gieldanowski J
    Folia Biol (Praha); 1977; 23(6):398-9. PubMed ID: 608476
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy of experimental allergic encephalomyelitis (EAE).
    Rosenthale ME; Datko LJ; Kassarich J; Schneider F
    Arch Int Pharmacodyn Ther; 1969 Jun; 179(2):251-75. PubMed ID: 5367302
    [No Abstract]   [Full Text] [Related]  

  • 4. Suppression of experimental allergic encephalomyelitis by NSC 82196, a new imidazole carboxamide derivative.
    Vogel CL; De Vita VT; Lisak RP; Kies MW
    Cancer Res; 1969 Dec; 29(12):2249-53. PubMed ID: 5369677
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunosuppressive treatment in neurological disorders].
    Aarli JA
    Tidsskr Nor Laegeforen; 1973 Jun; 93(18):1395-7. PubMed ID: 4356438
    [No Abstract]   [Full Text] [Related]  

  • 6. Suppression of experimental allergic encephalomyelitis in guinea-pigs with poly-L-lysine.
    Chelmicka-Szorc E; Arnason BG
    Clin Exp Immunol; 1975 Dec; 22(3):539-45. PubMed ID: 5213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental allergic encephalomyelitis. V. Therapeutic attempts with immunosuppressive and antiinflammatory drugs.
    Anghelescu N; Petrescu A; Chimion D
    Neurol Psychiatr (Bucur); 1979; 17(2):99-105. PubMed ID: 482840
    [No Abstract]   [Full Text] [Related]  

  • 8. Suppression of the hyperacute form of experimental allergic encephalomyelitis by drugs.
    Levine S; Sowinski R
    Arch Int Pharmacodyn Ther; 1977 Dec; 230(2):309-18. PubMed ID: 603323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged suppression of experimental allergic encephalomyelitis in the Lewis rats: the effect of lipopolysaccharides.
    Raziuddin S; Morrison DC
    J Immunol; 1982 Mar; 128(3):1486-9. PubMed ID: 6173441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of melengestrol acetate, cyclophosphamide and palmitoyl cytarabine in established experimental allergic encephalomyelitis of rats.
    Elliott GA; Gibbons AJ; Greig ME
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):62-76. PubMed ID: 4126903
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention of experimental allergic encephalomyelitis by immunological technics].
    Pellet H; Brun M; Camargo R; Girard P
    Rev Neurol (Paris); 1968 Feb; 118(2):133-40. PubMed ID: 4301748
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunoaugmenting effect of FK 506 on experimental allergic encephalomyelitis in Lewis rats.
    Chelmicka-Schorr E; Wiegmann K; Wollmann R; Arnason BG; Kim DH
    J Autoimmun; 1998 Aug; 11(4):329-34. PubMed ID: 9776710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribavirin reduces clinical signs and pathological changes of experimental autoimmune encephalomyelitis in Dark Agouti rats.
    Milicevic I; Pekovic S; Subasic S; Mostarica-Stojkovic M; Stosic-Grujicic S; Medic-Mijacevic L; Pejanovic V; Rakic L; Stojiljkovic M
    J Neurosci Res; 2003 Apr; 72(2):268-78. PubMed ID: 12672002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new antiserotonin in the carcinoid syndrome.
    Mengel CE; Lotito CA
    Arch Intern Med; 1968 Jun; 121(6):507-10. PubMed ID: 4870935
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells.
    Donia M; Mangano K; Amoroso A; Mazzarino MC; Imbesi R; Castrogiovanni P; Coco M; Meroni P; Nicoletti F
    J Autoimmun; 2009 Sep; 33(2):135-40. PubMed ID: 19625166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the effects of melengestrol acetate and hydrocortisone acetate on experimental allergic encephalomyelitis in rats.
    Greig ME; Gibbons AJ; Elliott GA
    J Pharmacol Exp Ther; 1970 May; 173(1):85-93. PubMed ID: 5442306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclophosphamide: effect on experimental allergic encephalomyelitis in Lewis rats.
    Paterson PY; Drobish DG
    Science; 1969 Jul; 165(3889):191-2. PubMed ID: 5787160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alkylans-alkylandum reactions. 8. Therapeutic effect of some cerebral serotonin liberators in nitrogen mustard intoxication of the mouse].
    Rauen HM; Schriewer H; Ferié F
    Arzneimittelforschung; 1972 Sep; 22(9):1474-6. PubMed ID: 4118856
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of various immunosuppressive agents on the vascular and cellular response to carvageenan in the rat.
    Dukes M; Chan WC; Willoughby DA
    J Pathol; 1973 Feb; 109(2):151-61. PubMed ID: 4720908
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclophosphamide treatment of experimental allergic encephalomyelitis in Lewis rats.
    Paterson PY
    J Immunol; 1971 Jun; 106(6):1473-9. PubMed ID: 4996791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.